Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
Background: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (ag...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860331704745984 |
---|---|
author | Rafat Shadmehr Mehdi Sharafi Mohammadhossien Shahabzadeh Mostafa Bijani Rahim Sharafkhani Babak Pezeshki Abdolmajid Ghasemian Azizallah Dehghan |
author_facet | Rafat Shadmehr Mehdi Sharafi Mohammadhossien Shahabzadeh Mostafa Bijani Rahim Sharafkhani Babak Pezeshki Abdolmajid Ghasemian Azizallah Dehghan |
author_sort | Rafat Shadmehr |
collection | DOAJ |
description | Background:
This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data.
Methods:
This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (aged 35–70 years) were studied. The MetS was defined as per the National Cholesterol Education Program ATP III (NCEP-ATP III) criteria. Independent sample t-test and Chi-square test were used for univariate analysis, and multivariate logistic regression was used to control for potential confounders and calculate odds ratios (ORs).
Results:
The MetS prevalence was 24.6% in the whole population (28.42% in women vs. 19.94% in men, P < 0.001). The prevalence of opium use was 23.2%. The odds of metabolic syndrome in smokers was lower than in non-smokers (OR = 1.17%, 95% CI 1.001–1.37).
Conclusions:
The results of this study showed that opium consumption has an inverse relationship with metabolic syndrome. However, this study was cross-sectional, and longitudinal studies are needed for more accurate conclusions. Opium is also a carcinogen. Therefore, its use is not recommended. |
format | Article |
id | doaj-art-2dbeddffe4ba45fbb7660e23ef414bc9 |
institution | Kabale University |
issn | 2008-7802 2008-8213 |
language | English |
publishDate | 2025-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | International Journal of Preventive Medicine |
spelling | doaj-art-2dbeddffe4ba45fbb7660e23ef414bc92025-02-10T15:22:27ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132025-01-011614410.4103/ijpvm.ijpvm_164_23Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based StudyRafat ShadmehrMehdi SharafiMohammadhossien ShahabzadehMostafa BijaniRahim SharafkhaniBabak PezeshkiAbdolmajid GhasemianAzizallah DehghanBackground: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (aged 35–70 years) were studied. The MetS was defined as per the National Cholesterol Education Program ATP III (NCEP-ATP III) criteria. Independent sample t-test and Chi-square test were used for univariate analysis, and multivariate logistic regression was used to control for potential confounders and calculate odds ratios (ORs). Results: The MetS prevalence was 24.6% in the whole population (28.42% in women vs. 19.94% in men, P < 0.001). The prevalence of opium use was 23.2%. The odds of metabolic syndrome in smokers was lower than in non-smokers (OR = 1.17%, 95% CI 1.001–1.37). Conclusions: The results of this study showed that opium consumption has an inverse relationship with metabolic syndrome. However, this study was cross-sectional, and longitudinal studies are needed for more accurate conclusions. Opium is also a carcinogen. Therefore, its use is not recommended.https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23metabolic syndromeopiumwaist circumference fasa |
spellingShingle | Rafat Shadmehr Mehdi Sharafi Mohammadhossien Shahabzadeh Mostafa Bijani Rahim Sharafkhani Babak Pezeshki Abdolmajid Ghasemian Azizallah Dehghan Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study International Journal of Preventive Medicine metabolic syndrome opium waist circumference fasa |
title | Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study |
title_full | Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study |
title_fullStr | Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study |
title_full_unstemmed | Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study |
title_short | Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study |
title_sort | associations of opium use with metabolic syndrome in fasa persian cohort study a population based study |
topic | metabolic syndrome opium waist circumference fasa |
url | https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23 |
work_keys_str_mv | AT rafatshadmehr associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT mehdisharafi associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT mohammadhossienshahabzadeh associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT mostafabijani associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT rahimsharafkhani associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT babakpezeshki associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT abdolmajidghasemian associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy AT azizallahdehghan associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy |